retatrutide clinical status Today we shared new results on retatrutide, an investigational, first-of-its-kind treatment we're studying in adults with obesity or overweight with at least one weight-related comorbidity. Read more about the Phase 3 findings:

There was a 30 fold rise in seizures of products claiming to be slimming and diabetes medicines last year., The Health Products Regulatory Authority seized 48,752 items presenting as GLP1 products in How the FDA's Semaglutide Ruling Impacts Aesthetics Practices: Navigating Compliance and Weight Loss Programs Compounded Semaglutide with B12: Everything You Need To Know As conversations around GLP 1 medications continue to grow, many families have questions about how these medications work and when they may be appropriate for children and teens. In a new blog, Dr.